Relapsed Adult AML
Oncology·MeSH: Leukemia, Myeloid, Acute
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| revumenib | HWH International Inc. (HWH) |
Phase 1(1)
| Drug | Company |
|---|---|
| zelenirstat | UNITED THERAPEUTICS Corp (UTHR) |
Compare drugs
Frequently asked questions
How many drugs are in development for Relapsed Adult AML?
BioSniper tracks 2 drugs in development for Relapsed Adult AML across 2 companies.
How many clinical trials target Relapsed Adult AML?
There are 2 clinical trials targeting Relapsed Adult AML tracked by BioSniper.
Deep-dive into Relapsed Adult AML
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis